Cervical intraepithelial neoplasia
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Cervical intraepithelial neoplasia, or CIN, is the abnormal growth of precancerous cells in the cervix. Most cases of CIN remain stable, or are eliminated by the host's immune system without intervention. However a small percentage of cases progress to become cervical cancer, usually cervical squamous cell carcinoma, or SCC.[1] The major cause of CIN is infection with the sexually transmitted human papillomavirus (HPV), usually the high-risk HPV types 16 or 18.
The earliest microscopic change corresponding to CIN is dysplasia of the epithelial or surface lining of the cervix, which is essentially undetectable by the woman. Cellular changes associated with HPV infection, such as koilocytes, are also commonly seen in CIN. It is usually discovered by a screening test, the Papanicolaou or "pap" smear. The purpose of this test is to diagnose the disease early, while it has not yet progressed to invasive carcinoma, and thus is easy to cure. Though epithelial dysplasia may regress spontaneously, persistent lesions must be removed, either with surgery, chemical burning, heat burning, burning with laser, or freezing (cryotherapy).
Grades
CIN has three distinct grades:
- CIN1 (Grade I), the least risky type, represents only mild dysplasia, or abnormal cell growth[1] and is considered a low grade squamous intraepithelial lesion (LGSIL). [2]. It is confined to the basal 1/3 of the epithelium.
- CIN2 (Grade II), as well as CIN III, are considered high grade squamous intraepithelial lesions (HSIL). [2] CIN2 represents moderate dysplasia, and is confined to the basal 2/3 of the epithelium
- CIN3 (Grade III): In this lesion, severe dysplasia spans greater than 2/3 of the the entire epithelium, and may involve the full thickness. This lesion may also be referred to as cervical carcinoma in situ.
Cervical intraepithelial neoplasia (1) normal squamous epithelium.jpg
Normal cervical epithelium (H&E stain). |
Cervical intraepithelial neoplasia (2) koilocytosis.jpg
Grade I CIN. |
Cervical intraepithelial neoplasia (3) CIN2.jpg
Grade II CIN. |
 Grade III CIN. |
Progression
Cases of CIN are thought by some to progress through these stages toward cancer in a linear fashion.[1][3][4]
However, evidence suggests that cancer can occur without first detectably progressing through these stages and that a high grade intraepithelial neoplasia can occur without first existing as a lower grade.[1][5]
See also
References
- ↑ 1.0 1.1 1.2 1.3 Agorastos T, Miliaras D, Lambropoulos A, Chrisafi S, Kotsis A, Manthos A, Bontis J (2005). "Detection and typing of human papillomavirus DNA in uterine cervices with coexistent grade I and grade III intraepithelial neoplasia: biologic progression or independent lesions?". Eur J Obstet Gynecol Reprod Biol 121 (1): 99-103. PMID 15949888.
- ↑ 2.0 2.1 Park J, Sun D, Genest D, Trivijitsilp P, Suh I, Crum C (1998). "Coexistence of low and high grade squamous intraepithelial lesions of the cervix: morphologic progression or multiple papillomaviruses?". Gynecol Oncol 70 (3): 386-91. PMID 9790792.
- ↑ Hillemanns P, Wang X, Staehle S, Michels W, Dannecker C (2006). "Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy". Gynecol Oncol 100 (2): 271-5. PMID 16169064.
- ↑ Rapp L, Chen J (1998). "The papillomavirus E6 proteins". Biochim Biophys Acta 1378 (1): F1-19. PMID 9739758.
- ↑ Monnier-Benoit S, Dalstein V, Riethmuller D, Lalaoui N, Mougin C, Prétet J (2006). "Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions". J Clin Virol 35 (3): 270-7. PMID 16214397.
bg:Цервикална интраепителна неоплазия sv:Cervikal intraepitelial neoplasi
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
